1-4 of 4
Michal Taszner, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 2 Study of Odronextamab (REGN1979), a CD20 x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Tae Min Kim, MD PhD, Arancha Alonso, MD, Miles Prince, MD, Michal Taszner, MD, Seok-Goo Cho, MD, PhD, Don A. Stevens, MD, Michelle Poon, MD, Francesca Lim, MBBS, BSc, MRCP (UK), Steven Le Gouill, MD PhD, Cecilia Carpio, MD, Mary-Margaret Keating, MD FRCPC, Lieve Adriaens, PharmD, Melanie Ufkin, PhD, Ayesha Sabir, BSc, Jingjin Li, PhD, Vladimir Jankovic, MD, Min Zhu, PhD, Jurriaan Brouwer-Visser, PhD, Siyang Leng, MD MS, L. Andres Sirulnik, MD PhD, Aafia Chaudhry, MD MBA, MS, Srikanth R. Ambati, MBBS, MD, Kim Won Seog, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-136344
Published: 2020
Journal Articles

Phase 2 Study Evaluating the Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Mantle Cell Lymphoma Not Previously Treated with a BTK Inhibitor (CITADEL-205)

Amitkumar Mehta, MD, Marek Trněný, MD, Jan Walewski, MD, Vincent Ribrag, MD, Caroline Dartigeas, MD, Jacob Haaber Christensen, MD PhD, Fabrizio Pane, MD, Guillermo Rodríguez, MD, Michal Taszner, MD, Parameswaran Venugopal, MD, Vittorio Ruggero Zilioli, MD, Fred Zheng, MD, Douglas J DeMarini, PhD, Wei Jiang, PhD, Pier Luigi Zinzani, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-134872
Published: 2020
Journal Articles

High-Dose Therapy Followed by Autologous HSCT in Patients with Multiple Myeloma. Results of a Retrospective Multicenter Analysis Conducted by The Polish Myeloma Group.

Wanda M. Knopinska-Posluszny, MD, PhD, Andrzej Hellmann, Michal Taszner, MD, Anna Dmoszynska, Wiktor Jedrzejczak, Jerzy Holowiecki, Jan Walewski, Krzysztof Warzocha, Aleksander Skotnicki, Andrzej Lange, Kazimierz Kuliczkowski, Kazimierz Sulek, M. Komarnicki, Tadeusz Robak
Journal: Blood
Blood (2007) 110 (11): 5108.
https://doi.org/10.1182/blood.V110.11.5108.5108
Published: 2007
Journal Articles

Clinical Outcome in Patients with AML Exhibiting Poor Mobilization of Progenitor Cells.

Wanda Knopinska-Posluszny, MD, PhD, Michal Taszner, MD, Jan M. Zaucha, MD, PHD, Lucja Kachel, MD, PHD, Anna Czyz, MD, PHD, Lidia Gil, MD, PHD, Jerzy Holowiecki, M. Komarnicki, Andrzej Hellmann
Journal: Blood
Blood (2006) 108 (11): 5439.
https://doi.org/10.1182/blood.V108.11.5439.5439
Published: 2006